Mounjaro Injection vs Ozempic: Key Differences
Mounjaro Injection and Ozempic are two widely discussed prescription medicines for managing type 2 diabetes. Both are given once weekly and can help improve blood sugar control, while their effects on appetite, digestion, and body weight have also made them subjects of considerable interest. However, they are not the same medication, and their active ingredients, mechanisms of action, approved uses, dosing schedules, and safety considerations differ. Mounjaro contains tirzepatide, which activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Ozempic contains semaglutide, which is a GLP-1 receptor agonist. Understanding these differences can help readers have a more informed discussion with a qualified healthcare professional about which treatment may be appropriate for their individual needs. What Is Mounjaro Injection? Mounjaro Injection contains tirzepatide and is administered once a week under the skin. In the United Stat...